CEAQ Singapore suit seeks 51,000 Tonbo shares or winding-up

CEAQ Singapore faces a pending Singapore High Court suit in which a minority shareholder seeks alternative remedies including 51,000 Tonbo equity shares, compensation or the winding-up of CEAQ Singapore. The claimant links the 51,000-share figure to 738 preference shares and an investment amount of Rs 75.06198 lakh.

Why is CEAQ Singapore facing a Singapore High Court suit?

CEAQ Singapore is facing the suit because the claimant alleges that it did not extend a preference-share subscription right available under a shareholders’ agreement. Mr. Harshad Ajit Lahoti, an individual investor and minority shareholder of CEAQ Singapore, filed the Singapore High Court suit against CEAQ Singapore, the Company and certain other parties. CEAQ Singapore has been served with the statement of claim, and the matter was pending as of the Red Herring Prospectus date.

The claimant alleges that a shareholders’ agreement between CEAQ Singapore and certain shareholders required CEAQ Singapore to offer its shareholders a right to subscribe to certain preference shares issued by the Company. He further alleges that the failure to provide that opportunity meant CEAQ Singapore’s affairs were conducted in a manner oppressive to, or in disregard of, his interests. The prospectus identifies the claimant as a CEAQ Singapore shareholder, not a shareholder of the Company.

The dispute therefore concerns whether rights held by CEAQ Singapore as a Company shareholder had to be passed to CEAQ Singapore shareholders. The claim’s outcome depends on the Singapore High Court’s treatment of the shareholders’ agreement, the alleged subscription right and the claimant’s oppression allegation. No court ruling, settlement or quantified liability was disclosed in the prospectus.

What remedies does the CEAQ Singapore suit seek?

The CEAQ Singapore suit seeks one of four alternative remedies intended to address the claimant’s alleged loss of a preference-share allotment. The first requested remedy is a purchase of all the claimant’s CEAQ Singapore shares at fair value, with appropriate adjustments, plus the value of equity shares that would have resulted from the preference shares. The claimant calculates that conversion outcome as 51,000 equity shares in the Company.

The second remedy requested is winding-up of CEAQ Singapore. The third is an opportunity for the claimant to acquire 51,000 equity shares in the Company for Rs 75.06198 lakh. The fourth is equitable compensation equal to the value of the 51,000 equity shares, less the original Rs 75.06198 lakh investment amount payable for 738 preference shares.

These remedies are presented as alternatives rather than cumulative awards. The claim connects the 51,000 equity shares with conversion of specified preference shares, while the stated Rs 75.06198 lakh consideration applies to 738 preference shares. Any financial effect would depend on the remedy, if any, selected by the court and its determination of fair value, adjustments or equitable compensation.

How has the Company responded to the CEAQ Singapore claim?

The Company has stated that it had no obligation to offer preference shares to the CEAQ Singapore claimant. The claimant sent legal notices dated April 10, 2026 and July 15, 2026 to the Company and CEAQ Singapore. Those notices alleged that, because he was a CEAQ Singapore shareholder, the Company should have extended the preference-share issuance and any related rights to him.

The Company replied by letters dated May 4, 2026 and July 24, 2026. It said there was no contractual privity, meaning a direct contractual relationship, between the claimant and the Company through CEAQ Singapore. On that stated basis, the Company said it was not required to offer the preference shares to the claimant.

The disclosed procedural position differs among defendants. CEAQ Singapore received the statement of claim, whereas the Company said it had received an October 2, 2026 letter from the claimant’s lawyers notifying it of the suit but had not been served with suit papers as of the prospectus date. The named directors were aware of the suit through public-domain searches and had not received claim papers as of that date.

How material is the CEAQ Singapore suit in the prospectus?

The CEAQ Singapore suit is the group-company proceeding disclosed as potentially having a material impact on the Company. The same Singapore matter is also recorded as one material civil litigation against the Company, the promoter and managing director and chief executive officer, and the nominee director. The prospectus identifies overlapping parties in one proceeding rather than separate civil cases.

The board’s materiality policy, adopted on August 4, 2026, sets a materiality amount of Rs 3.203 crore. That amount is the lowest of 2% of Fiscal 2026 turnover, Rs 7.253 crore; 2% of net worth at March 31, 2026, Rs 11.063 crore; and 5% of the average absolute profit or loss after tax for the preceding three fiscals, Rs 3.203 crore. The policy also requires disclosure of unquantifiable civil litigation if the result could materially affect the Company’s business, operations, financial position or reputation.

The Singapore suit does not disclose an aggregate damages demand, but it includes potential share-based, compensation and winding-up remedies. Separately, the prospectus reports six tax proceedings against the Company, including five indirect-tax proceedings involving Rs 3.562 crore. Those tax proceedings are distinct from the Singapore civil claim.

What will determine the next CEAQ Singapore update?

The next CEAQ Singapore update will depend on further procedural steps and the Singapore High Court’s assessment of the shareholders’ agreement. The central unresolved question is whether CEAQ Singapore had to extend to its shareholders the right to subscribe to preference shares issued by the Company. The Company’s disclosed position is that no contractual privity existed between it and the claimant.

A later update could also show whether the claimant continues to pursue winding-up, a CEAQ Singapore share purchase, an opportunity to acquire 51,000 equity shares or equitable compensation. The prospectus records that CEAQ Singapore had been served, while the Company had not been served with legal papers as of the prospectus date. The matter’s practical effect will depend on a court decision or another disclosed resolution.

Conclusion

CEAQ Singapore’s pending suit concerns an alleged right to participate in a preference-share issuance and the claimant’s calculation that conversion would have produced 51,000 equity shares. The case puts the shareholders’ agreement, the alleged duty to extend subscription rights and the Company’s contractual-privity position at the centre of the dispute. The remedies sought range from compensation and a share-related outcome to winding-up of CEAQ Singapore.

What to watch next is service on the remaining defendants and the Singapore High Court’s assessment of the claimed contractual right. The prospectus discloses that CEAQ Singapore received the statement of claim, but the Company had not received suit papers as of the prospectus date. Any subsequent ruling on oppression, fair value, conversion-linked shares or winding-up would establish the claim’s effect.